# pathway_0175

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **A** — Cofactor biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVEEIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDCKLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLGSNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKGADYLRTHDVKSLSDALKISKALG

[Multiple Choices]
A. Cofactor biosynthesis
B. molybdopterin biosynthesis. .
C. L-homoserine from L-aspartate: step 2/3. .
D. NAD(+) from deamido-NAD(+) (L-Gln route): step 1/1. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated as dihydropteroate synthase type-3, with a pathway annotation of cofactor biosynthesis and tetrahydrofolate biosynthesis. The annotation is supported by computational evidence and a cited publication; the evidence also records structural and functional work on the protein.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The choices concern distinct metabolic routes, but the supplied sequence and context provide no clear, generally accessible cue that identifies its pathway without first identifying its protein family or function.


**Missing item-specific fact**

> That this sequence is dihydropteroate synthase type-3, which participates in tetrahydrofolate biosynthesis.


**Reason**

> The key is supported by the matched protein annotation, but that protein-specific identity and pathway assignment are absent from the evaluated input. Recognizing the exact sequence or consulting a protein annotation would distinguish the choices; that is lookup or memorization, not a sequence-based biological argument supplied by the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> A is the broad pathway category annotated for the protein. The more specific tetrahydrofolate-biosynthesis pathway is not offered; the other choices name different pathways.


### Important caveats

- The pathway annotation includes RuleBase computational evidence as well as a publication citation; it should not be treated as exclusively experimental evidence.
- Reviewer-only evidence establishes support for the key but was not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The choices concern distinct metabolic routes, but the supplied sequence and context provide no clear, generally accessible cue that identifies its pathway without first identifying its protein family or function.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this sequence is dihydropteroate synthase type-3, which participates in tetrahydrofolate biosynthesis.",
    "reason": "The key is supported by the matched protein annotation, but that protein-specific identity and pathway assignment are absent from the evaluated input. Recognizing the exact sequence or consulting a protein annotation would distinguish the choices; that is lookup or memorization, not a sequence-based biological argument supplied by the question."
  },
  "case_id": "pathway_0175",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as dihydropteroate synthase type-3, with a pathway annotation of cofactor biosynthesis and tetrahydrofolate biosynthesis. The annotation is supported by computational evidence and a cited publication; the evidence also records structural and functional work on the protein."
  },
  "important_caveats": [
    "The pathway annotation includes RuleBase computational evidence as well as a publication citation; it should not be treated as exclusively experimental evidence.",
    "Reviewer-only evidence establishes support for the key but was not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "A is the broad pathway category annotated for the protein. The more specific tetrahydrofolate-biosynthesis pathway is not offered; the other choices name different pathways."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0175",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as dihydropteroate synthase type-3, with a pathway annotation of cofactor biosynthesis and tetrahydrofolate biosynthesis. The annotation is supported by computational evidence and a cited publication; the evidence also records structural and functional work on the protein.",
    "evidence_ids": ["C4", "C5", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The choices concern distinct metabolic routes, but the supplied sequence and context provide no clear, generally accessible cue that identifies its pathway without first identifying its protein family or function.",
    "missing_item_specific_fact": "That this sequence is dihydropteroate synthase type-3, which participates in tetrahydrofolate biosynthesis.",
    "reason": "The key is supported by the matched protein annotation, but that protein-specific identity and pathway assignment are absent from the evaluated input. Recognizing the exact sequence or consulting a protein annotation would distinguish the choices; that is lookup or memorization, not a sequence-based biological argument supplied by the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "A is the broad pathway category annotated for the protein. The more specific tetrahydrofolate-biosynthesis pathway is not offered; the other choices name different pathways."
  },
  "important_caveats": [
    "The pathway annotation includes RuleBase computational evidence as well as a publication citation; it should not be treated as exclusively experimental evidence.",
    "Reviewer-only evidence establishes support for the key but was not available to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry C0HMD9 (sequence matched, 263 aa) annotates this protein as Dihydropteroate synthase type-3 (sul3, EC 2.5.1.15) with pathway 'Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2.' Option A ('Cofactor biosynthesis') matches the top-level pathway category exactly. The other options (molybdopterin biosynthesis, L-homoserine from L-aspartate, NAD+ biosynthesis) are unrelated pathways and are not supported by any annotation for this protein.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the well-known 'DPGMG' catalytic motif (positions ~168-172: 'IILDPGMGFFLGSNPETS'), which is a signature of dihydropteroate synthase (DHPS) family enzymes. DHPS catalyzes the condensation of dihydropterin pyrophosphate with p-aminobenzoate in folate biosynthesis. Folate (tetrahydrofolate) is a cofactor, placing this enzyme in 'Cofactor biosynthesis.' The distractors involve entirely different enzyme families: molybdopterin biosynthesis uses MoaD/MoaC/MoaE (transferase/carbamoyltransferase folds), L-homoserine from L-aspartate uses aspartate kinase/semialdehyde dehydrogenase/homoserine dehydrogenase (oxidoreductase/kinase folds), and NAD+ biosynthesis uses NadD/NadE (nucleotidyltransferase/adenylyltransferase folds). None of these families carry the DPGMG DHPS signature, allowing a knowledgeable biologist to exclude B, C, and D based on sequence architecture.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The DPGMG motif is a concrete, identifiable sequence feature present in the provided sequence. Recognizing it as a DHPS catalytic signature and tracing the logical chain (DHPS → folate biosynthesis → cofactor) constitutes a defensible biological argument. The distractors involve structurally and mechanistically distinct enzyme classes that lack this motif, making them distinguishable through general enzymology knowledge without needing to memorize this specific protein's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Option A is the only pathway category consistent with DHPS/folate biosynthesis. Option B (molybdopterin biosynthesis) is a different cofactor pathway with unrelated enzymes. Options C and D are amino acid and nucleotide biosynthesis pathways, respectively, with no mechanistic overlap with DHPS. The wording and choices are sufficiently distinct.


### Important caveats

- The protein is a plasmid-encoded sul3 variant (DHPS type-3) from E. coli, not the chromosomal folP/folK DHPS. The pathway annotation is nonetheless identical (tetrahydrofolate biosynthesis).
- The pathway annotation carries ECO:0000255 (RuleBase, computational) and ECO:0000303 (PubMed, inferred from assertion) evidence codes, supplemented by X-ray crystallography (ECO:0007744) confirming catalytic activity and substrate binding.
- Recognition of the DPGMG motif as a DHPS signature requires familiarity with enzyme family motifs; a model without this knowledge would likely need database lookup.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the well-known 'DPGMG' catalytic motif (positions ~168-172: 'IILDPGMGFFLGSNPETS'), which is a signature of dihydropteroate synthase (DHPS) family enzymes. DHPS catalyzes the condensation of dihydropterin pyrophosphate with p-aminobenzoate in folate biosynthesis. Folate (tetrahydrofolate) is a cofactor, placing this enzyme in 'Cofactor biosynthesis.' The distractors involve entirely different enzyme families: molybdopterin biosynthesis uses MoaD/MoaC/MoaE (transferase/carbamoyltransferase folds), L-homoserine from L-aspartate uses aspartate kinase/semialdehyde dehydrogenase/homoserine dehydrogenase (oxidoreductase/kinase folds), and NAD+ biosynthesis uses NadD/NadE (nucleotidyltransferase/adenylyltransferase folds). None of these families carry the DPGMG DHPS signature, allowing a knowledgeable biologist to exclude B, C, and D based on sequence architecture.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The DPGMG motif is a concrete, identifiable sequence feature present in the provided sequence. Recognizing it as a DHPS catalytic signature and tracing the logical chain (DHPS → folate biosynthesis → cofactor) constitutes a defensible biological argument. The distractors involve structurally and mechanistically distinct enzyme classes that lack this motif, making them distinguishable through general enzymology knowledge without needing to memorize this specific protein's database entry."
  },
  "case_id": "pathway_0175",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry C0HMD9 (sequence matched, 263 aa) annotates this protein as Dihydropteroate synthase type-3 (sul3, EC 2.5.1.15) with pathway 'Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2.' Option A ('Cofactor biosynthesis') matches the top-level pathway category exactly. The other options (molybdopterin biosynthesis, L-homoserine from L-aspartate, NAD+ biosynthesis) are unrelated pathways and are not supported by any annotation for this protein."
  },
  "important_caveats": [
    "The protein is a plasmid-encoded sul3 variant (DHPS type-3) from E. coli, not the chromosomal folP/folK DHPS. The pathway annotation is nonetheless identical (tetrahydrofolate biosynthesis).",
    "The pathway annotation carries ECO:0000255 (RuleBase, computational) and ECO:0000303 (PubMed, inferred from assertion) evidence codes, supplemented by X-ray crystallography (ECO:0007744) confirming catalytic activity and substrate binding.",
    "Recognition of the DPGMG motif as a DHPS signature requires familiarity with enzyme family motifs; a model without this knowledge would likely need database lookup."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option A is the only pathway category consistent with DHPS/folate biosynthesis. Option B (molybdopterin biosynthesis) is a different cofactor pathway with unrelated enzymes. Options C and D are amino acid and nucleotide biosynthesis pathways, respectively, with no mechanistic overlap with DHPS. The wording and choices are sufficiently distinct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0175",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry C0HMD9 (sequence matched, 263 aa) annotates this protein as Dihydropteroate synthase type-3 (sul3, EC 2.5.1.15) with pathway 'Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2.' Option A ('Cofactor biosynthesis') matches the top-level pathway category exactly. The other options (molybdopterin biosynthesis, L-homoserine from L-aspartate, NAD+ biosynthesis) are unrelated pathways and are not supported by any annotation for this protein.",
    "evidence_ids": ["C4", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the well-known 'DPGMG' catalytic motif (positions ~168-172: 'IILDPGMGFFLGSNPETS'), which is a signature of dihydropteroate synthase (DHPS) family enzymes. DHPS catalyzes the condensation of dihydropterin pyrophosphate with p-aminobenzoate in folate biosynthesis. Folate (tetrahydrofolate) is a cofactor, placing this enzyme in 'Cofactor biosynthesis.' The distractors involve entirely different enzyme families: molybdopterin biosynthesis uses MoaD/MoaC/MoaE (transferase/carbamoyltransferase folds), L-homoserine from L-aspartate uses aspartate kinase/semialdehyde dehydrogenase/homoserine dehydrogenase (oxidoreductase/kinase folds), and NAD+ biosynthesis uses NadD/NadE (nucleotidyltransferase/adenylyltransferase folds). None of these families carry the DPGMG DHPS signature, allowing a knowledgeable biologist to exclude B, C, and D based on sequence architecture.",
    "missing_item_specific_fact": "",
    "reason": "The DPGMG motif is a concrete, identifiable sequence feature present in the provided sequence. Recognizing it as a DHPS catalytic signature and tracing the logical chain (DHPS → folate biosynthesis → cofactor) constitutes a defensible biological argument. The distractors involve structurally and mechanistically distinct enzyme classes that lack this motif, making them distinguishable through general enzymology knowledge without needing to memorize this specific protein's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option A is the only pathway category consistent with DHPS/folate biosynthesis. Option B (molybdopterin biosynthesis) is a different cofactor pathway with unrelated enzymes. Options C and D are amino acid and nucleotide biosynthesis pathways, respectively, with no mechanistic overlap with DHPS. The wording and choices are sufficiently distinct."
  },
  "important_caveats": [
    "The protein is a plasmid-encoded sul3 variant (DHPS type-3) from E. coli, not the chromosomal folP/folK DHPS. The pathway annotation is nonetheless identical (tetrahydrofolate biosynthesis).",
    "The pathway annotation carries ECO:0000255 (RuleBase, computational) and ECO:0000303 (PubMed, inferred from assertion) evidence codes, supplemented by X-ray crystallography (ECO:0007744) confirming catalytic activity and substrate binding.",
    "Recognition of the DPGMG motif as a DHPS signature requires familiarity with enzyme family motifs; a model without this knowledge would likely need database lookup."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `C0HMD9` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 2. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C0HMD9.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:26.472274+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000250","id":"P0C002","source":"UniProtKB"}],"value":"Dihydropteroate pyrophosphorylase type III"}},{"fullName":{"evidences":[{"evidenceCode":"ECO:0000250","id":"P0C002","source":"UniProtKB"}],"value":"Dihydropteroate synthase type III"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000255","id":"RU361205","source":"RuleBase"},{"evidenceCode":"ECO:0000269","id":"37419898","source":"PubMed"}],"value":"2.5.1.15"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","id":"RU361205","source":"RuleBase"},{"evidenceCode":"ECO:0000303","id":"37419898","source":"PubMed"}],"value":"Dihydropteroate synthase type-3"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000255","id":"RU361205","source":"RuleBase"},{"evidenceCode":"ECO:0000303","id":"37419898","source":"PubMed"}],"value":"DHPS"}]}}
```

Source SHA-256: `ba9202b2e0fdfb687773d6b94fecc4e21695a959dd67b21c7814fcafd1f756dd`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C0HMD9.json)  
**Locator:** `/comments/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:26.472274+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000255","id":"RU361205","source":"RuleBase"},{"evidenceCode":"ECO:0000303","id":"37419898","source":"PubMed"}],"value":"Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2"}]}
```

Source SHA-256: `ba9202b2e0fdfb687773d6b94fecc4e21695a959dd67b21c7814fcafd1f756dd`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C0HMD9?format=txt&versions=2)  
**Locator:** `lines 26-35`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 2 / 1.  
**Retrieved:** 2026-11-02T04:27:30.074117+00:00.  

```text
RN   [2] {ECO:0007744|PDB:7S2L, ECO:0007744|PDB:7S2M, ECO:0007744|PDB:8SCD}
RP   X-RAY CRYSTALLOGRAPHY (2.06 ANGSTROMS) IN APO FORM AND IN COMPLEXES WITH
RP   MG(2+) AND WITH SUBSTRATES, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF PHE-177 AND LEU-179.
RX   PubMed=37419898; DOI=10.1038/s41467-023-39778-7;
RA   Venkatesan M., Fruci M., Verellen L.A., Skarina T., Mesa N., Flick R.,
RA   Pham C., Mahadevan R., Stogios P.J., Savchenko A.;
RT   "Molecular mechanism of plasmid-borne resistance to sulfonamide
RT   antibiotics.";
RL   Nat. Commun. 14:4031-4031(2023).
```

Source SHA-256: `471448fab7cd4dd0e76b2ade89d1ed2965f5d7c7a78add137146b1544b0047d8`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C0HMD9?format=txt&versions=2)  
**Locator:** `lines 63-66`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 2 / 1.  
**Retrieved:** 2026-11-02T04:27:30.074117+00:00.  

```text
CC   -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 7,8-
CC       dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-
CC       dihydropteridine diphosphate and 4-aminobenzoate: step 1/2.
CC       {ECO:0000255|RuleBase:RU361205, ECO:0000303|PubMed:37419898}.
```

Source SHA-256: `471448fab7cd4dd0e76b2ade89d1ed2965f5d7c7a78add137146b1544b0047d8`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 175. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
